Evidence map›Paper›PMID 35475263›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2022

Association of vitamin K with cognitive decline and neuropathology in community-dwelling older persons.

Sarah L Booth, M Kyla Shea, Kathryn Barger, Sue E Leurgans, Bryan D James, Thomas M Holland, Puja Agarwal, Xueyan Fu, Jifan Wang, Gregory Matuszek and 1 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Vitamin K and women's health: a review.Frontiers in global women's health · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah L BoothJean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston Massachusetts USA.
M Kyla SheaJean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston Massachusetts USA.ORCID https://orcid.org/0000-0002-3202-5582
Kathryn BargerJean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston Massachusetts USA.
Sue E LeurgansRush Alzheimer's Disease Center Rush University Chicago Illinois USA.
Bryan D JamesRush Alzheimer's Disease Center Rush University Chicago Illinois USA.
Thomas M HollandDepartment of Neurological Sciences Rush University Chicago Illinois USA.
Puja AgarwalDepartment of Neurological Sciences Rush University Chicago Illinois USA.
Xueyan FuJean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston Massachusetts USA.
Jifan WangJean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston Massachusetts USA.
Gregory MatuszekJean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston Massachusetts USA.
Julie A SchneiderRush Alzheimer's Disease Center Rush University Chicago Illinois USA.

Funding

EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Vitamins D and K and Neuropathologically-Defined Alzheimer and Other Dementias in Older PersonsRF1AG051641 · NIA · TUFTS UNIVERSITY BOSTON · PI BOOTH, SARAH LOUISE · 2016 to 2016
$3.7M
Vitamin K and D and Cognitive Impairment in Older AdultsR01AG051641 · NIA · TUFTS UNIVERSITY BOSTON · PI BOOTH, SARAH LOUISE · 2022 to 2025
$2.7M
NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG051641NIA NIH HHS RF1 AG051641
6 · The paper itself

Abstract

Higher vitamin K intakes have been associated with better cognitive function, suggestive of a vitamin K mechanistic effect or simply reflective of a healthy diet. To test the hypothesis that brain vitamin K is linked to cognitive decline and dementia, vitamin K concentrations were measured in four brain regions, and their associations with cognitive and neuropathological outcomes were estimated in 325 decedents of the Rush Memory and Aging Project. Menaquinone-4 (MK4) was the main vitamin K form in the brain regions evaluated. Higher brain MK4 concentrations were associated with a 17% to 20% lower odds of dementia or mild cognitive impairment (MCI) (

Indexed as

agingAlzheimer's diseasecognitive declinedementianeuropathologynutritionvitamin K

Identifiers

PMID35475263
PMCPMC9019903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.